Maternal rescue of transforming growth factor-beta 1 null mice.

Maternal sources of transforming growth factor-beta 1 (TGF-beta 1) are shown here to contribute to the normal appearance and perinatal survival of TGF-beta 1 null newborn mice. Labeled TGF-beta 1 crossed the placenta and was recovered intact from various tissues after oral administration to mouse pups. TGF beta-1 protein was also detected in cells recovered from breast milk. In immunohistochemical analyses, TGF-beta 1 null embryos and null newborn pups born to TGF-beta 1 heterozygotes stained positive for TGF-beta 1, whereas those born to a null female were negative and had severe cardiac abnormalities. These results suggest an important role for maternal sources of TGF-beta 1 during development and, more generally, provide evidence for maternal rescue of targeted gene disruption in the fetus.

[1]  K. Ozato,et al.  Transfer of antibodies directed to paternal major histocompatibility class I antigens from pregnant mice to the developing fetus. , 1987, Journal of immunology.

[2]  D. Kingsley,et al.  The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. , 1994, Genes & development.

[3]  R. Suzuki,et al.  Transmission of maternal blood cells to the fetus during pregnancy: detection in mouse neonatal spleen by immunofluorescence flow cytometry and polymerase chain reaction. , 1994, Blood.

[4]  M. Sporn,et al.  Transforming growth factor-beta 1: histochemical localization with antibodies to different epitopes , 1989, The Journal of cell biology.

[5]  J. Head,et al.  Uptake of lymphocytes fed to suckling rats. An autoradiographic study of the transit of labeled cells through the neonatal gastric mucosa. , 1987, Journal of reproductive immunology.

[6]  D. Danielpour.  Improved sandwich enzyme-linked immunosorbent assays for transforming growth factor beta 1. , 1993, Journal of immunological methods.

[7]  D. Doniach,et al.  ABERRANT EXPRESSION OF HLA-DR ANTIGEN ON THYROCYTES IN GRAVES' DISEASE: RELEVANCE FOR AUTOIMMUNITY , 1983, The Lancet.

[8]  H. Erickson,et al.  Gene knockouts of c-src, transforming growth factor beta 1, and tenascin suggest superfluous, nonfunctional expression of proteins , 1993, The Journal of cell biology.

[9]  M. Sporn,et al.  Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[10]  D. Dresser.  The influence of maternal humoral responsiveness on the specific immunocompetence of the progeny in mice. , 1990, Journal of reproductive immunology.

[11]  M. Sporn,et al.  Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution. , 1990, The Journal of clinical investigation.

[12]  M. Sporn,et al.  Transforming growth factor beta 1 (TGF-beta 1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-beta 1 null mouse phenotype. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[13]  D. Abrahamson,et al.  Evidence for the sorting of endocytic vesicle contents during the receptor-mediated transport of IgG across the newborn rat intestine , 1981, The Journal of cell biology.

[14]  G. Proetzel,et al.  Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease , 1992, Nature.

[15]  R. Billingham,et al.  Capacity of "transplanted" lymphocytes to traverse the intestinal epithelium of adult rats. , 1981, Transplantation.

[16]  S. Mckercher,et al.  Repression of major histocompatibility complex IA expression by glucocorticoids: the glucocorticoid receptor inhibits the DNA binding of the X box DNA binding protein , 1993, The Journal of experimental medicine.

[17]  M. Sporn,et al.  Role of transforming growth factor-beta in the development of the mouse embryo , 1987, The Journal of cell biology.

[18]  R. R. Bürk,et al.  Isolation and characterisation of milk growth factor, a transforming-growth-factor-beta 2-related polypeptide, from bovine milk. , 1991, European journal of biochemistry.

[19]  D. R. Gamble,et al.  In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. , 1985, The New England journal of medicine.

[20]  A. Ullrich,et al.  Onset of endogenous synthesis of epidermal growth factor in neonatal mice. , 1987, Developmental biology.

[21]  P. Kondaiah,et al.  Embryonic gene expression patterns of TGF beta 1, beta 2 and beta 3 suggest different developmental functions in vivo. , 1991, Development.

[22]  M. Sporn,et al.  Sandwich Enzyme-Linked Immunosorbent Assays (Selisas) Quantitate and Distinguish Two Forms of Transforming Growth Factor-Beta (TGF-β1 and TGF-β2) in Complex Biological Fluids , 1989 .

[23]  H. Tokuyama,et al.  Bovine colostric transforming growth factor-beta-like peptide that induces growth inhibition and changes in morphology of human osteogenic sarcoma cells (MG-63). , 1989, Cell biology international reports.